Probiosis-5

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
23-11-2017

유효 성분:

Saccharomyces cerevisiae (Boulardii), Quantity: 5 billion CFU; Lactobacillus gasseri, Quantity: 2 billion CFU; Lactobacillus reuteri, Quantity: 3 billion CFU; Bifidobacterium breve, Quantity: 5 billion CFU; Lactobacillus rhamnosus, Quantity: 5 billion CFU

제공처:

Spectrumceuticals Pty Ltd

INN (International Name):

Bifidobacterium breve,Lactobacillus gasseri,Lactobacillus reuteri,Lactobacillus rhamnosus,Saccharomyces cerevisiae (Boulardii)

약제 형태:

Capsule, hard

구성:

Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; purified water

관리 경로:

Oral

치료 징후:

Maintain/support general health and wellbeing ; Maintain/support intestinal health ; Maintain/support intestinal good/beneficial/friendly flora ; Maintain/support small intestine good/beneficial/friendly flora ; Maintain/support gastrointestinal system health ; Maintain/support gastrointestinal mucosal membrane health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support healthy gastrointestinal immune function

제품 요약:

Visual Identification: ;

승인 상태:

Licence status A

승인 날짜:

2017-09-13

문서 기록보기